Additively manufactured medical products – the FDA perspective

  • Di Prima M
  • Coburn J
  • Hwang D
  • et al.
N/ACitations
Citations of this article
425Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The treatment of craniofacial defects can present many challenges due to the variety of tissue-specific requirements and the complexity of anatomical structures in that region. 3D-printing technologies provide clinicians, engineers and scientists with the ability to create patient-specific solutions for craniofacial defects. Currently, there are three key strategies that utilize these technologies to restore both appearance and function to patients: rehabilitation, reconstruction and regeneration. In rehabilitation, 3D-printing can be used to create prostheses to replace or cover damaged tissues. Reconstruction, through plastic surgery, can also leverage 3D-printing technologies to create custom cutting guides, fixation devices, practice models and implanted medical devices to improve patient outcomes. Regeneration of tissue attempts to replace defects with biological materials. 3D-printing can be used to create either scaffolds or living, cellular constructs to signal tissue-forming cells to regenerate defect regions. By integrating these three approaches, 3D-printing technologies afford the opportunity to develop personalized treatment plans and design-driven manufacturing solutions to improve aesthetic and functional outcomes for patients with craniofacial defects.

Cite

CITATION STYLE

APA

Di Prima, M., Coburn, J., Hwang, D., Kelly, J., Khairuzzaman, A., & Ricles, L. (2016). Additively manufactured medical products – the FDA perspective. 3D Printing in Medicine, 2(1). https://doi.org/10.1186/s41205-016-0005-9

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free